Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences (TSE:ATLE)
:ATLE
Total Valuation
Willow Biosciences Inc has a market cap or net worth of C$88.06M. The enterprise value is ―.
Market CapC$88.06M
Enterprise Value―
Share Statistics
Willow Biosciences Inc has 352,222,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding352,222,660
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Willow Biosciences Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count19
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Willow Biosciences Inc is ―. Willow Biosciences Inc’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Willow Biosciences Inc had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Willow Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.64
52-Week Price Change-58.33%
50-Day Moving Average0.16
200-Day Moving Average0.30
Relative Strength Index (RSI)56.96
Average Volume (3m)105.37K
Important Dates
Willow Biosciences Inc upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Willow Biosciences Inc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Willow Biosciences Inc has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Willow Biosciences Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Willow Biosciences Inc has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Willow Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast571.23%
EPS Growth Forecast64.25%